Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China · Delayed Price · Currency is CNY 14.17
+0.03 (0.21%)
At close: Mar 6, 2026
Shenzhen YHLO Biotech Revenue
In the year 2025, Shenzhen YHLO Biotech had annual revenue of 1.81B CNY, down -10.07%. Shenzhen YHLO Biotech had revenue of 522.40M in the quarter ending December 31, 2025, a decrease of -15.44%.
Revenue
1.81B
Revenue Growth
-10.07%
P/S Ratio
4.48
Revenue / Employee
1.08M
Employees
1,678
Market Cap
8.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -202.51M | -10.07% |
| Dec 31, 2024 | 2.01B | -41.48M | -2.02% |
| Dec 31, 2023 | 2.05B | -1.93B | -48.42% |
| Dec 31, 2022 | 3.98B | 2.80B | 237.95% |
| Dec 31, 2021 | 1.18B | 178.89M | 17.91% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Sinocare | 4.71B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.33B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.69B |
| Beijing Wandong Medical Technology | 1.62B |
| Xiangyu Medical Co.,Ltd | 767.75M |